1. Home
  2. Live Updates
  3. Erck kgaa

Live Breaking News & Updates on Erck kgaa

Stay informed with the latest breaking news from Erck kgaa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Erck kgaa and stay connected to the pulse of your community

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients With Advanced Urothelial Carcinoma

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial.

Germany , Toronto , Ontario , Canada , United-states , Italy , France , Italian , American , Srikala-sridhar , American-society-of-clinical-oncology , Merck-press

Investegate |Merck KGaA Announcements | Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Investegate announcements from Merck KGaA, Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Investegate announcements from Merck KGaA, Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

After Corona success: Moderna leaves hope for a cancer vaccine

According to new study results, a drug from the corona vaccine manufacturer Moderna could also protect against skin cancer. The stock market is enthusiastic about the news. The German competitor Biontech is also benefiting.

United-states , American , Merck-co , Nasdaq , New-york-listed , Mainz-based-moderna , Moderna , Erck-kgaa , Sin-de0006599905 , Sin-us6311011026 , Ancer-vaccine

Immutep in clinical trail collaboration with Merck KGaA and Pfizer

Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer - News - PharmaTimes

Germany , Krankenhaus-nordwest , Marc-voigt , Pfizer , Merck-kga , Merck-kgaa , Institute-of-clinical-cancer-research , Clinical-cancer-research , Immutep- , Rial- , Erck-kgaa ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,